8-OH-PBZI
8-OH-PBZI je lek koji se koristi u naučnim istraživanjima. On deluje kao potentan i selektivan agonist dopaminskog D3 receptora.[1][2][3]
![]() | |
IUPAC ime | |
---|---|
(3aS,9bR)-3-propil-1,2,3a,4,5,9b-heksahidrobenzo[e]indol-8-ol | |
Identifikatori | |
ATC kod | none |
PubChem | CID 10353845 |
ChemSpider | 8529297 ![]() |
Hemijski podaci | |
Formula | C15H21NO |
Molarna masa | 231,333 g/mol |
| |
|
Reference
уреди- ^ Scheideler, MA; Martin, J; Hohlweg, R; Rasmussen, JS; Naerum, L; Ludvigsen, TS; Larsen, PJ; Korsgaard, N; Crider, AM (1997). „The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain”. European journal of pharmacology. 339 (2–3): 261—70. PMID 9473144. doi:10.1016/S0014-2999(97)01372-1.
- ^ Fink-Jensen, A; Nielsen, EB; Hansen, L; Scheideler, MA (1998). „Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI”. European journal of pharmacology. 342 (2–3): 153—61. PMID 9548380. doi:10.1016/S0014-2999(97)01494-5.
- ^ Malik, P; Andersen, MB; Peacock, L (2004). „The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia”. Pharmacology, biochemistry, and behavior. 78 (4): 805—10. PMID 15301939. doi:10.1016/j.pbb.2004.05.019.